Tag: kidney transplantation

Fistula ligation “should become a routine part of post-transplant care”

At this year’s Vascular Access for Hemodialysis Symposium (9–11 June, Charleston, USA), Alexander Toledo (University of North Carolina, Chapel Hill, USA) asserted the advantages...

AlloVir reports preliminary data on posoleucel for BK viraemia in kidney...

AlloVir has announced preliminary, blinded data from an ongoing Phase 2 study of posoleucel—an investigational, allogeneic, off-the-shelf, multi-virus-specific T cell (VST) therapy for the...

NICE recommends Idefirix in treatment of highly sensitised kidney transplant recipients

Hansa Biopharma has announced a recommendation by the National Institute for Health and Care Excellence (NICE) for its first-in-class treatment Idefirix (imlifidase) in the...

Select solid-organ transplant recipients may remain at high Omicron risk despite...

While a fourth vaccine dose does increase anti-spike immunoglobin-G (IgG) and neutralising capacity against many COVID-19 variants of concern (VOCs), some solid-organ transplant recipients...

First patient dosed in study evaluating TX200 cell therapy product for...

Sangamo Therapeutics has announced dosing of the first patient in the Phase 1/2 STEADFAST clinical study evaluating TX200—an investigational, wholly owned, autologous chimeric antigen...

Retransplantation may offer greater survival outcomes than dialysis following a failed...

As per a clinical study involving more than 2,300 adult patients, a second kidney transplant is likely to offer improved survival outcomes when compared...

Natera announces study results showing “excellent” positive predictive value of Prospera...

Natera has announced the results of a large clinical experience study confirming the "strong performance" of its Prospera donor-derived cell-free DNA (dd-cfDNA) test in...

Transplantation discrepancies contribute to racial disparities in childhood-onset kidney failure survival...

Transplantation discrepancies between Black and white patients have been found to contribute significantly to differing survival rates for childhood-onset kidney failure across the two...
pig kidneys transplantation

Transplantation of gene-edited pig kidneys in decedent human model is “game-changing...

Peer-reviewed research outlining the successful transplant of genetically modified, clinical-grade pig kidneys into a brain-dead human individual has been published in the American Journal...

DaVita expands efforts in kidney transplantation with MedSleuth acquisition

DaVita has announced the acquisition of transplant software company MedSleuth, which works with US transplant centres to improve experiences and outcomes for kidney and...

GIRFT report represents “call to action” and provides renewed focus for...

The Getting It Right First Time (GIRFT) national report on renal medicine represents a “call to action” for the UK renal community, and provides...

Standard vaccination regimens may not provide adequate protection against new SARS-CoV-2...

Kidney transplant recipients tend to mount impaired antibody responses against emerging SARS-CoV-2 variants after standard two-dose COVID-19 vaccination, according to a study published in the...

Hansa Biopharma enrols first patient in US pivotal trial of kidney...

Hansa Biopharma recently announced that the first patient has been enrolled in its CONFIDES trial—a US pivotal, open-label, randomised controlled study—at the Columbia University Medical Center...

Promising histological marker of kidney graft failure identified by new study

An observational study published in the Journal of the American Society of Nephrology (JASN) has identified a “promising” histological marker for determining kidney transplant...
organox

OrganOx completes £6.4 million equity fundraise to boost utilisation of donated...

OrganOx, the producer of the 'metra' normothermic machine perfusion (NMP) product, has announced the completion of a £6.4 million equity fundraise. The fundraise was...

Natera validates kidney transplant rejection test in multicentre, prospective Trifecta study

Natera has announced initial results from the global, multicentre, prospective Trifecta study, which assessed its Prospera with quantification test for kidney transplant rejection and was led by Phil...

Transformative moment marks progress in xenotransplantation

The first investigational transplantation of a genetically engineered, non-human kidney to a human body was recently completed at NYU Langone Health, New York, USA—marking...

Fresenius Medical Care North America announces three key clinical leadership appointments

Fresenius Medical Care North America (FMCNA) has announced three key clinical leadership appointments to help drive priorities, including improving patient outcomes, adopting connected health technologies...
kidney project ibak

Bioartificial kidney device receives KidneyX award after progressing to preclinical model

An implantable bioartificial kidney device (iBAK)—which promises to free kidney disease patients from dialysis machines and transplant waiting lists—has taken another step towards becoming...

Natera launches Prospera with quantification to improve kidney graft rejection testing

Natera has announced the launch of Prospera with quantification, the only cell-free DNA (cfDNA) test for kidney rejection that provides three values—the quantity of...

ESOT 2021: Asian donor and Black recipient kidney grafts associated with...

Black transplant recipients and patients who received kidneys from Asian donors had a significantly higher risk of their kidney grafts failing within seven years,...
kidney transplantation covid-19

ESOT 2021: Kidney transplants plummeted by 40% during first wave of...

The number of solid organ transplants performed during the first wave of the COVID-19 pandemic in 2020 plunged by nearly a third (31%) compared...
evergreen nephrology

Rubicon Founders launches Evergreen Nephrology with intent to “transform” kidney care

Rubicon Founders has announced the launch of Evergreen Nephrology—a company partnering with nephrologists to transform kidney care, according to a press release. Evergreen is...

Pilot study of third COVID-19 vaccine dose in kidney transplant recipients...

A pilot study has begun to assess the antibody response to a third dose of an authorised COVID-19 mRNA vaccine in kidney transplant recipients...
NKF transplant recommendations

NKF publishes recommendations to move thousands of patients from dialysis to...

The National Kidney Foundation (NKF) has released a position paper, developed by 16 nephrology experts from 13 institutions, with recommendations designed to navigate future research...
kidney graft survival rates

Hansa Biopharma announces three-year graft survival of 84% after imlifidase treatment...

Hansa Biopharma has announced three-year follow-up data on graft survival rates in crossmatch positive patients who received imlifidase prior to kidney transplantation. As reported...
kidney transplant referrals

Higher kidney transplant referral rates found in non-profit dialysis facilities versus...

New research indicates that patients with kidney failure who receive care at for-profit dialysis facilities are less likely to be referred for kidney transplants...
geko device

Novel device reduces swelling and surgical site infection after kidney transplantation

Researchers from the Lawson Health Research Institute at London Health Sciences Centre (LHSC) in London, Canada have reported that a simple medical device reduced...